Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Optical Preclinical Imaging Market Outlook

The global optical preclinical imaging market size was valued at USD 640.4 million in 2023, driven by rising technical advancements in optical imaging facilitating smooth drug development across the globe. The market is expected to grow at a CAGR of 5% during the forecast period of 2024-2032, with the values likely to rise from USD 672.4 million in 2024 to USD 992.5 million by 2032.

Optical Preclinical Imaging: Introduction

Preclinical imaging is an essential diagnostic and research tool used in drug development and discovery. Preclinical imaging includes micro-ultrasound, optical imaging, CT, PET, and MRIs, among others. Optical imaging is divided into bioluminescence and fluorescence. It is rapid, easy to perform, and is commonly used for molecular visualizations. It can prove to be highly effective for the pharmaceutical industry as it enables the prior analysis of drugs in pipeline, facilitating faster drug development.

Global Optical Preclinical Imaging Market Analysis

The sudden outbreak of COVID-19 and increasing prevalence of chronic diseases has expediated drug and vaccine development. With the ongoing trend of machine learning and artificial intelligence, the healthcare industry is witnessing the convergence of new technologies into medical ecosystem. This is has led to significant optical preclinical imaging market demand.

Animals are often used as the initial model for testing and determining the effects of a drug. However, collecting the data sets can be difficult, owing to their different sizes and physical positions. To solve this problem, InVivo analytics has developed a fast cloud-based data analysis platform called InVIvoAX. Imaging software like Harmony® and Columbus™ are being used for high content imaging, data storage and analysis.

The optical preclinical imaging market growth can also be accredited to the advent of new imaging technologies. Researchers have introduced imaging mass cytometry to analyze the detection of proteins within tissue sections with the help of heavy metal tagged antibodies. In September 2023, Revvity Inc., unveiled an enhanced imaging portfolio in preclinical research which includes IVIS® Spectrum 2 and the IVIS SpectrumCT 2 imaging systems, crafted to elevate the sensitivity standards in in vivo optical imaging.

To facilitate fast-tracking and rapid evaluation of therapeutic candidates, Revvity's QuantumTM GX3 microCT structural imaging solution has been enabled with increased resolution and speed for both in vivo and ex vivo imaging. Such product launches will add significant growth the optical preclinical imaging market value.

Global Optical Preclinical Imaging Market Segmentation

Market Breakup by Modality

  • Bioluminescence/Fluorescence Imaging Systems
  • Standalone Fluorescence Imaging Systems
  • Optical + X-Ray/ Optical + CT

Market Breakup by Reagent

  • Bioluminescent Imaging Reagents
  • Fluorescent Imaging Reagent

Market Breakup by Application

  • Research and Development
  • Drug Discovery

Market Breakup by End User

  • Pharma and Biotech Companies
  • Research Institutes
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Optical Preclinical Imaging Market Overview

The United States is expected to lead the optical preclinical imaging market share with the implementation of the Inflation Reduction Act of 2022. This act emphasizes the reduction of device and drug prices in the country. This indicates that the traditional research and development methods will take a backseat as the pharma companies keenly adopt machine learning and artificial intelligence technology driven platforms to accelerate drug development. The integration has already been initiated and it is fairly smooth, owing to the presence of a robust healthcare infrastructure.

Europe has been one of the leading regions in the market as it is home to several academic institutions, pioneering research and development in numerous healthcare domains. Asia Pacific is also expected to witness the fastest growth attributed to rising medical infrastructure development. In addition, major healthcare companies have been making hefty investments in the region to leverage the easy availability of both economical and intellectual resources.

Global Optical Preclinical Imaging Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • Stryker
  • Smith+Nephew
  • NuVasive Inc.
  • Arthrex Inc. 
  • Orthofix US LLC
  • Johnson & Johnson Services, Inc.
  • Pega Medical Inc.
  • WishBone Medical
  • Zimmer Biomet
  • Medtronic
  • Auxein Medical
  • Implanet SA
  • Merete GmbH
  • Mighty Oak Medical

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Modality
  • Reagent
  • Application
  • End User
  • Region
Breakup by Modality
  • Bioluminescence/Fluorescence Imaging Systems
  • Standalone Fluorescence Imaging Systems
  • Optical + X-Ray/ Optical + CT
Breakup by Reagent
  • Bioluminescent Imaging Reagents
  • Fluorescent Imaging Reagent
Breakup by Application
  • Research and Development
  • Drug Discovery
Breakup by End User
  • Pharma and Biotech Companies
  • Research Institutes
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Stryker
  • Smith+Nephew
  • NuVasive Inc.
  • Arthrex Inc.
  • Orthofix US LLC
  • Johnson & Johnson Services, Inc.
  • Pega Medical Inc.
  • WishBone Medical
  • Zimmer Biomet
  • Medtronic
  • Auxein Medical
  • Implanet SA
  • Merete GmbH
  • Mighty Oak Medical

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!

Key Questions Answered in the Report

The market attained a value of about USD 640.4 million in 2023, driven by the increasing prevalence of chronic diseases across the globe.

The market is anticipated to grow at a CAGR of 5% during the forecast period of 2024-2032, likely to reach a market value of USD 992.5 million by 2032.

The key drivers include ongoing trend of machine learning and artificial intelligence, the healthcare industry.

Artificial intelligence and machine learning integration in the pharmaceutical industry is the current market trend. InVivo analytics has launched a cloud-based data analysis platform called InVIvoAX. Harmony® and Columbus™ are software used for high content imaging, data storage and analysis.

Common application areas include research and development and drug discovery.

Bioluminescent imaging reagents and fluorescent imaging reagents are commonly used.

It includes Bioluminescence/Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems and Optical + X-Ray/ Optical + CT.

Major end users include research institutes, pharma and biotech companies, among others.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.

Key players involved in the market are Stryker, Smith+Nephew, NuVasive Inc., Arthrex Inc., Orthofix US LLC, Johnson & Johnson Services, Inc., Pega Medical Inc., WishBone Medical, Zimmer Biomet, Medtronic, Auxein Medical, Implanet SA, Merete GmbH, and Mighty Oak Medical.

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Pricing Plans

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Strategic Solutions for Informed Decision-Making

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124